WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic

Hypertension

Volumn 46, Issue 4, 2005, Pages 758-765

  Turner, Stephen T ^a   Schwartz, Gary L ^a   Chapman, Arlene B ^b   Boerwinkle, Eric ^c  

^a MAYO CLINIC   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Blood pressure; Diuretics; Genetics; Polymorphism

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA 2 ADRENERGIC RECEPTOR; CHLORIDE CHANNEL; COTRANSPORTER; FUROSEMIDE; HYDROCHLOROTHIAZIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL; LYSINE; MINERALOCORTICOID RECEPTOR; POTASSIUM; POTASSIUM CHLORIDE; PROTEIN KINASE; SODIUM; SODIUM CHANNEL; SODIUM CHANNEL BETA; SODIUM CHANNEL GAMMA; SODIUM CHLORIDE; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; ETHNOLOGY; FEMALE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SODIUM TRANSPORT; SODIUM URINE LEVEL; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADULT; BIOLOGICAL TRANSPORT; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DIASTOLE; EPITHELIAL SODIUM CHANNEL; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ADRENERGIC, BETA-2; SODIUM; SODIUM CHANNELS; SODIUM CHLORIDE SYMPORTER INHIBITORS; SYSTOLE;

EID: 31944439902     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000186240.81996.57     Document Type: Article

References (21)

1. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104:545-556.
2. Turner ST, Schwartz GL, Chapman AB, Boerwinkle E. C825T polymorphism of the G protein beta(3)-subunit and antihypertensive response to a thiazide diuretic. Hypertension. 2001;37:739-743.
3. Schwartz GL, Turner ST, Chapman AB, Boerwinkle E. Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide. Kidney Int. 2002;62:1718-1723.
4. Frazier L, Turner ST, Schwartz GL, Chapman AB, Boerwinkle E. Multilocus effects of the renin-angiotensin-aldosterone system genes on blood pressure response to a thiazide diuretic. Pharmacogenomics J. 2004;4:17-23.
5. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, Glorioso N, Lanzani C, Manunta P, Righetti M, Rivera R, Stella P, Troffa C, Zagato L, Bianchi G. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet. 1997;349:1353-1357.
6. Chapman AB, Schwartz GL, Boerwinkle E, Turner ST. Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension. Kidney Int. 2002;61:1047-1055.
7. Abecasis GR, Cookson WO. GOLD - graphical overview of linkage disequilibrium. Bioinformatics. 2000;16:182-183.
8. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet. 2003;73:1162-1169.
9. Turner ST, Chapman AB, Schwartz GL, Boerwinkle E. Effects of endothelial nitric oxide synthase, alpha-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide. Am J Hypertens. 2003;16:834-839.
10. Appel LJ. The verdict from ALLHAT - thiazide diuretics are the preferred initial therapy for hypertension. J Am Med Assoc. 2002;288:3039-3042.
11. Preston RA, Materson BJ, Reda DJ, Williams DW, Hamburger RJ, Cushman WC, Anderson RJ. Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. J Am Med Assoc. 1998;280:1168-1172.
12. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Feely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP. Human hypertension caused by mutations in WNK kinases. Science. 2001;293:1107-1112.
13. Yang CL, Angell J, Mitchell R, Ellison DH. WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest. 2003;111:1039-1045.
14. Kahle KT, Wilson FH, Lalioti M, Toka H, Qin H, Lifton RP. WNK kinases: molecular regulators of integrated epithelial ion transport. Curr Opin Nephrol Hypertens. 2004;13:557-562.
15. Finkielman JD, Schwartz GL, Chapman AB, Boerwinkle E, Turner ST. Reproducibility of blood pressure response to hydrochlorothiazide. J Clin Hypertens (Greenwich). 2002;4:408-412.
16. Finkielman JD, Schwartz GL, Chapman AB, Boerwinkle E, Turner ST. Lack of agreement between office in ambulatory blood pressure responses to hydrochlorothiazide. Am J Hypertens. 2005;18:389-402.
17. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Am Med Assoc. 2002;288:2981-2997.
18. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-2446.
19. Meissner I, Whisnant JP, Sheps SG, Schwartz GL, O'Fallon WM, Covalt JL, Sicks JD, Bailey KR, Wiebers DO. Detection and control of high blood pressure in the community: Do we need a wake-up call? Hypertension. 1999;34:466-471.
20. Turner ST, Schwartz GL, Chapman AB, Hall WD, Boerwinkle E. Antihypertensive pharmacogenetics: getting the right drug into the right patient. J Hypertens. 2001;19:1-11.
21. Laragh JH, Lamport B, Sealey J, Alderman MH. Diagnosis ex juvantibus. Individual response patterns to drugs reveal hypertension mechanisms and simplify treatment. Hypertension. 1988;12:223-226.